These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 21340481
1. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Olsen A, Christensen J, Knudsen KE, Johnsen NF, Overvad K, Tjønneland A. Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481 [Abstract] [Full Text] [Related]
2. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Guglielmini P, Rubagotti A, Boccardo F. Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938 [Abstract] [Full Text] [Related]
4. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A. Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765 [Abstract] [Full Text] [Related]
5. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort. Kyrø C, Hansen L, Frederiksen K, Nørskov NP, Bach Knudsen KE, Eriksen AK, Holm M, Tjønneland A, Olsen A. Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112 [Abstract] [Full Text] [Related]
7. An incident case-referent study on plasma enterolactone and breast cancer risk. Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585 [Abstract] [Full Text] [Related]
8. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Piller R, Chang-Claude J, Linseisen J. Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865 [Abstract] [Full Text] [Related]
12. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women. Aarestrup J, Kyrø C, Knudsen KE, Weiderpass E, Christensen J, Kristensen M, Würtz AM, Johnsen NF, Overvad K, Tjønneland A, Olsen A. Br J Nutr; 2013 Jun 28; 109(12):2269-75. PubMed ID: 23114205 [Abstract] [Full Text] [Related]
13. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers. Jaskulski S, Jung AY, Behrens S, Johnson T, Kaaks R, Thöne K, Flesch-Janys D, Sookthai D, Chang-Claude J. Int J Cancer; 2018 Dec 01; 143(11):2698-2708. PubMed ID: 29974464 [Abstract] [Full Text] [Related]
14. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Xie J, Tworoger SS, Franke AA, Terry KL, Rice MS, Rosner BA, Willett WC, Hankinson SE, Eliassen AH. Breast Cancer Res Treat; 2013 Jun 01; 139(3):801-9. PubMed ID: 23760859 [Abstract] [Full Text] [Related]
15. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P. Cancer Epidemiol Biomarkers Prev; 1998 Oct 01; 7(10):885-9. PubMed ID: 9796633 [Abstract] [Full Text] [Related]
16. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort. Kyrø C, Frederiksen K, Holm M, Nørskov NP, Knudsen KEB, Overvad K, Tjønneland A, Olsen A. Br J Nutr; 2019 Sep 14; 122(5):552-563. PubMed ID: 30173678 [Abstract] [Full Text] [Related]
18. Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer. Eriksen AK, Kyrø C, Nørskov N, Bolvig AK, Christensen J, Tjønneland A, Overvad K, Landberg R, Olsen A. Eur J Clin Nutr; 2017 Oct 14; 71(10):1235-1240. PubMed ID: 28378849 [Abstract] [Full Text] [Related]
19. Urinary phytoestrogens and postmenopausal breast cancer risk. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. Cancer Epidemiol Biomarkers Prev; 2001 Mar 14; 10(3):223-8. PubMed ID: 11303591 [Abstract] [Full Text] [Related]
20. Weight gain prior to diagnosis and survival from breast cancer. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Cancer Epidemiol Biomarkers Prev; 2007 Sep 14; 16(9):1803-11. PubMed ID: 17855698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]